Inhibition of gluconeogenesis by hypoglycin: alternate interpretations.
Tanaka
K
K
D000818:Animals; D003521:Cyclopropanes / Q000494:pharmacology*; D044943:Fatty Acid Desaturases / Q000037:antagonists & inhibitors; D005943:Gluconeogenesis / Q000187:drug effects*; D005952:Glucose-6-Phosphatase / Q000037:antagonists & inhibitors*; D006801:Humans; D007003:Hypoglycemia / Q000139:chemically induced; D007005:Hypoglycins / Q000494:pharmacology*; D008099:Liver / Q000166:cytology / Q000201:enzymology / Q000378:metabolism*; D010939:Plant Poisoning / Q000209:etiology / Q000378:metabolism; D051381:Rats
D003521:Cyclopropanes; D007005:Hypoglycins; C041757:hypoglycin; D044943:Fatty Acid Desaturases; D005952:Glucose-6-Phosphatase